Inositol trisphosphate 3-kinase B (InsP3KB) as a physiological modulator of myelopoiesis

Inositol trisphosphate 3-kinase B (InsP3KB) belongs to a family of kinases that convert inositol 1,4,5-trisphosphate (Ins(1,4,5)P3 or IP3) to inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4). Previous studies have shown that disruption of InsP3KB leads to impaired T cell and B cell development as...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 105; no. 12; pp. 4739 - 4744
Main Authors Jia, Yonghui, Loison, Fabien, Hattori, Hidenori, Li, Yitang, Erneux, Christophe, Park, Shin-Young, Gao, Chong, Chai, Li, Silberstein, Leslie E, Schurmans, Stephane, Luo, Hongbo R
Format Journal Article Web Resource
LanguageEnglish
Published United States National Academy of Sciences 25.03.2008
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Inositol trisphosphate 3-kinase B (InsP3KB) belongs to a family of kinases that convert inositol 1,4,5-trisphosphate (Ins(1,4,5)P3 or IP3) to inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4). Previous studies have shown that disruption of InsP3KB leads to impaired T cell and B cell development as well as hyperactivation of neutrophils. Here, we demonstrate that InsP3KB is also a physiological modulator of myelopoiesis. The InsP3KB gene is expressed in all hematopoietic stem/progenitor cell populations. In InsP3KB null mice, the bone marrow granulocyte monocyte progenitor (GMP) population was expanded, and GMP cells proliferated significantly faster. Consequently, neutrophil production in the bone marrow was enhanced, and the peripheral blood neutrophil count was also substantially elevated in these mice. These effects might be due to enhancement of PtdIns(3,4,5)P3/Akt signaling in the InsP3KB null cells. Phosphorylation of cell cycle-inhibitory protein p21cip¹, one of the downstream targets of Akt, was augmented, which can lead to the suppression of the cell cycle-inhibitory effect of p21.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
scopus-id:2-s2.0-42449122333
Author contributions: Y.J., H.H., and H.R.L. designed research; Y.J., F.L., H.H., and Y.L. performed research; C.E., S.-Y.P., C.G., L.C., L.E.S., and S.S. contributed new reagents/analytic tools; Y.J. and H.R.L. analyzed data; and Y.J. and H.R.L. wrote the paper.
Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved January 31, 2008
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.0800218105